Professor Marion Bennie

Strathclyde Institute of Pharmacy and Biomedical Sciences

Personal statement

Marion is a qualified pharmacist who graduated from The Robert Gordon's University with a BSc in Pharmacy followed by a MSc in Clinical Pharmacy at the Universtiy of Strathclyde. She obtained an Advanced Diploma in Clinical Pharmacy Teaching from the University of Leeds.

She holds a senior joint appointment with the NHS in Scotland as Chief Pharmacist, Public Health and intelligence, National Services Scotland which provides national and specialist services across Scotland. In 2008 Marion took up a 50% appointment as Professor of Pharmacy Practice in SIPBS.

Publications

Development of a web-based application to improve data collection of antimicrobial utilization in the public health care system in South Africa: Kruger D, Dlamini NN, Meyer JC, Godman B, Kurdi A, Lennon M, Bennie M, Schellack N; Hospital Practice Vol 49, pp. 184-193 (2021); https://doi.org/10.1080/21548331.2021.1889213
Development of a primary care pharmacy outcomes framework : an umbrella literature review: Weir Natalie M, Preston Kate, Newham Rosemary, Bennie Marion; Research in Social and Administrative Pharmacy (2021); https://doi.org/10.1016/j.sapharm.2021.07.010
Persistence and adherence to non-vitamin K antagonist oral anticoagulant treatment in patients with atrial fibrillation across five Western European countries: Komen JJ, Pottegård A, Mantel-Teeuwisse AK, Forslund T, Hjemdahl P, Wettermark B, Hellfritzsch M, Hallas J, Olesen M, Bennie M, Mueller T, Voss A, Schink T, Haug U, Kollhorst B, Karlstad Ø, Kjerpeseth LJ, Klungel OH; EP Europace (2021); https://doi.org/10.1093/europace/euab091
A point prevalence survey of antimicrobial utilisation patterns and quality indices amongst hospitals in South Africa; findings and implications: Skosana PP, Schellack N, Godman B, Kurdi A, Bennie M, Kruger D, Meyer JC; Expert Review of Anti-infective Therapy (2021); https://doi.org/10.1080/14787210.2021.1898946
Impact of EMA regulatory label changes on hydroxyzine initiation, discontinuation and switching to other medicines in Denmark, Scotland, England and the Netherlands : an interrupted time series regression analysis: Morales Daniel R, Macfarlane Tatiana, MacDonald Thomas M, Hallas Jesper, Ernst Martin Thomsen, Herings Ron M C, Smits Elisabeth, Overbeek Jetty A, Mitchell Lyn, Morant Steven, Mackenzie Isla, Doney Alexander S F, Robertson Chris, Bennie Marion, Wei Li, Nicholson Lizzie, Morris Carole, Flynn Robert WF; Pharmacoepidemiology and Drug Safety Vol 30, pp. 482-491 (2021); https://doi.org/10.1002/pds.5191
Point prevalence survey of antimicrobial utilisation patterns among public hospitals in South Africa using a newly developed app; findings and implications: Godman B, PP Skosana, Schellack N, Kurdi A, Bennie M, Kruger D, Meyer JC; British Society for Antimicrobial Chemotherapy Spring Conference 2021 (2021)

More publications

Research interests

Marion's research portfolio is focused on development of a robust evidence base to support the safe, effective and person centred care through use of medicines and other health technologies. Key areas of interest:

Pharmacoepidemiology
Pharmacy Practice
Healthcare Interventions

Professional activities

Scanning technology within community pharmacies: a friend or foe?: Contributor; 13/1/2021
Upskilling and intensification of work; are robots the answer?: Contributor; 22/8/2019
Safety climate within primary care: development and psychometric evaluation of a community pharmacy tool.: Contributor; 30/4/2014

More professional activities

Projects

Primary Care Pharmacy Resilience: Pharmacotherapy Service in Time of COVID-19: Newham, Rosemary (Principal Investigator) Bennie, Marion (Principal Investigator) Dunlop, Emma (Researcher) Weir, Natalie Mcfadyen (Researcher) Ferguson, Aimee Margaret Denver (Researcher); To explore the effect of COVID-19 on pharmacy teams working within General Practice to deliver the pharmacotherapy service. This project considers the pharmacotherapy service’s evolution due to changing practice – and priorities – under COVID-19.; 04-Jan-2021
Implementation of the pharmacotherapy service within primary care: health outcomes evaluation: Newham, Rosemary (Co-investigator) Bennie, Marion (Principal Investigator) Weir, Natalie Mcfadyen (Researcher) Dunlop, Emma (Researcher) Ferguson, Aimee Margaret Denver (Researcher); This work focuses on developing an outcomes framework for a Scottish context to allow the impact of the pharmacotherapy service to be evaluated.; 01-Jan-2021
Cardiovascular disease and COVID-19: using UK-wide linked routine healthcare data to address the impact of cardiovascular disease on COVID-19 and the impact of COVID-19 on cardiovascular diseases: Bennie, Marion (Principal Investigator) Kurdi, Amanj (Co-investigator) Kavanagh, Kimberley (Co-investigator); 16-Jan-2020 - 16-Jan-2021
Scottish Patient Safety Programme: NSAID carebundle rollout: Newham, Rosemary (Co-investigator) Weir, Natalie Mcfadyen (Researcher) Bennie, Marion (Principal Investigator); 06-Jan-2020
Assessment of cardiovascular diseases risk profile and management in HIV-infected patients in Kenya: A local situation analysis to inform future development of quality improvement interventions: Kurdi, Amanj (Principal Investigator) ACHIENG, Loice (Principal Investigator) Bennie, Marion (Co-investigator) Godman, Brian (Co-investigator) Kavanagh, Kimberley (Co-investigator) Megiddo, Itamar (Co-investigator); 01-Jan-2019 - 31-Jan-2020
GP Pharmacist Evaluation Project 2: Bennie, Marion (Principal Investigator) Newham, Rosemary (Co-investigator) Preston, Kate Elizabeth (Researcher) Weir, Natalie Mcfadyen (Researcher); 03-Jan-2019 - 31-Jan-2022

More projects

Address

Strathclyde Institute of Pharmacy and Biomedical Sciences
Robertson Wing

Location Map

View University of Strathclyde in a larger map